Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The use of local anaesthesia efficiently reduces pain due to needle puncture. However, when tuberculin skin test is performed it is the skin reaction to tuberculin injection that is studied. It is a quantitative skin reaction measured in millimiters. From the study of literature it is not known whether local anaesthetic modify skin reaction to tuberculin. Therefore, before recommending the use local anaesthesia for tuberculin intradermal injection we have to rule out a potential effect of local anaesthetic on the result of the test. This is particularly important in children, since there are more sensitive to pain than adults
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| lidocaine / Prilocaine | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of tuberculin skin tests reaction performed with and without | ||
| local anaesthesia, in a child (intra subject reproducibility) |
| Measure | Description | Time Frame |
|---|---|---|
| influence of local anaesthesia use, on tuberculin skin test interpretation | ||
| between observer reproducibility | ||
| pain evaluation in child over 5 years of age between tuberculin skin tests performed with and without local anaesthesia |
Not provided
Inclusion Criteria:
hospitalized or non hospitalized infant or child (3 months-15 years)requiring a tuberculin skin test, in our hospital. hospitalized 1 to 3 months old infants requiring a tuberculin skin test, in our hospital.
-
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nicole Beydon, MD | Contact | +33 140 032 000 | nicole.beydon@rdb.aphp.fr | |
| Estelle Marcault, ARC | Contact | +33 140 256 252 | estelle.marcault@bch.aphp.fr |
| Name | Affiliation | Role |
|---|---|---|
| Nicole Beydon, MD | APHP | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Robert Debré Hospital | Paris | 75019 | France |
Not provided
| ID | Term |
|---|---|
| D014376 | Tuberculosis |
| D010146 | Pain |
| ID | Term |
|---|---|
| D009164 | Mycobacterium Infections |
| D000193 | Actinomycetales Infections |
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077442 | Lidocaine, Prilocaine Drug Combination |
| ID | Term |
|---|---|
| D008012 | Lidocaine |
| D000083 | Acetanilides |
| D000813 | Anilides |
| D000577 | Amides |
| D009930 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| relationship between local anaesthesia use and failure to perform a correct intradermal injection |
| local tolerance to lidocaine / prilocaine |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| Organic Chemicals |
| D011318 | Prilocaine |
| D000814 | Aniline Compounds |
| D000588 | Amines |
| D004338 | Drug Combinations |
| D004364 | Pharmaceutical Preparations |